Related references
Note: Only part of the references are listed.Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Rosa Nguyen et al.
CLINICAL CANCER RESEARCH (2019)
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical Trial
Julie R. Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Wayne L. Furman et al.
CLINICAL CANCER RESEARCH (2019)
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
Chao Yang et al.
NATURE COMMUNICATIONS (2019)
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Yuanbin Song et al.
NATURE COMMUNICATIONS (2019)
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E. Barry et al.
CLINICAL CANCER RESEARCH (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma
Rosa Nguyen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier et al.
IMMUNITY (2018)
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart et al.
NATURE (2017)
Evaluation of the correlations between patient-derived xenograft (PDX) model-based mouse trials and cancer patient-based clinical trials.
Zhenyu Gu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Development and characterization of a human orthotopic neuroblastoma xenograft
Elizabeth Stewart et al.
DEVELOPMENTAL BIOLOGY (2015)
Cell biological steps and checkpoints in accessing NK cell cytotoxicity
Emily M. Mace et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine
Anthony Rongvaux et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Scott Kopetz et al.
CLINICAL CANCER RESEARCH (2012)
Monocytes derived from humanized neonatal NOD/SCID/IL2Rγnull mice are phenotypically immature and exhibit functional impairments
Christian Gille et al.
HUMAN IMMUNOLOGY (2012)
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Joaquim Calbo et al.
CANCER CELL (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence
Till Strowig et al.
BLOOD (2010)
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
M. Wunderlich et al.
LEUKEMIA (2010)
Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
W. Leung et al.
BRITISH JOURNAL OF CANCER (2007)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Development of a human adaptive immune system in cord blood cell-transplanted mice
E Traggiai et al.
SCIENCE (2004)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Share Paper
